Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer. [electronic resource]
Producer: 20030910Description: 4898-904 p. digitalISSN:- 0950-9232
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Hormonal -- therapeutic use
- Breast Neoplasms -- chemistry
- Cell Cycle
- Chemotherapy, Adjuvant
- Cohort Studies
- Combined Modality Therapy
- Cyclin E -- analysis
- Disease-Free Survival
- Female
- Humans
- Lymphatic Metastasis
- Mastectomy
- Mastectomy, Segmental
- Menopause
- Middle Aged
- Neoplasm Proteins -- analysis
- Prognosis
- Proportional Hazards Models
- Radiotherapy, Adjuvant
- Receptors, Estrogen -- analysis
- Receptors, Progesterone -- analysis
- Retrospective Studies
- Survival Analysis
- Treatment Failure
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.